From the Departments of Radiology (L.D.H., C.K.H., A.H., S.J.K.), Pulmonology (D.G.P., T.M.F., D.S.P., J.Y., C.K.H., K.M.K., N.H.K.), and Cardiothoracic Surgery (V.P., M.M.M.), University of California San Diego School of Medicine, 9300 Campus Point Dr, La Jolla, CA 92037-0841; and Department of Radiology, Stanford School of Medicine, Palo Alto, Calif (J.S.).
Radiographics. 2023 Feb;43(2):e220078. doi: 10.1148/rg.220078.
Management of chronic thromboembolic pulmonary hypertension (CTEPH) should be determined by a multidisciplinary team, ideally at a specialized CTEPH referral center. Radiologists contribute to this multidisciplinary process by helping to confirm the diagnosis of CTEPH and delineating the extent of disease, both of which help determine a treatment decision. Preoperative assessment of CTEPH usually employs multiple imaging modalities, including ventilation-perfusion (V/Q) scanning, echocardiography, CT pulmonary angiography (CTPA), and right heart catheterization with pulmonary angiography. Accurate diagnosis or exclusion of CTEPH at imaging is imperative, as this remains the only form of pulmonary hypertension that is curative with surgery. Unfortunately, CTEPH is often misdiagnosed at CTPA, which can be due to technical factors, patient-related factors, radiologist-related factors, as well as a host of disease mimics including acute pulmonary embolism, in situ thrombus, vasculitis, pulmonary artery sarcoma, and fibrosing mediastinitis. Although V/Q scanning is thought to be substantially more sensitive for CTEPH compared with CTPA, this is likely due to lack of recognition of CTEPH findings rather than a modality limitation. Preoperative evaluation for pulmonary thromboendarterectomy (PTE) includes assessment of technical operability and surgical risk stratification. While the definitive therapy for CTEPH is PTE, other minimally invasive or noninvasive therapies also lead to clinical improvements including greater survival. Complications of PTE that can be identified at postoperative imaging include infection, reperfusion edema or injury, pulmonary hemorrhage, pericardial effusion or hemopericardium, and rethrombosis. RSNA, 2022
慢性血栓栓塞性肺动脉高压(CTEPH)的管理应由多学科团队决定,理想情况下在专门的 CTEPH 转诊中心进行。放射科医生通过帮助确认 CTEPH 的诊断和描绘疾病的范围为这一多学科过程做出贡献,这两者都有助于确定治疗决策。CTEPH 的术前评估通常采用多种成像方式,包括通气-灌注(V/Q)扫描、超声心动图、CT 肺动脉造影(CTPA)和带肺动脉造影的右心导管检查。在影像学上准确诊断或排除 CTEPH 至关重要,因为这仍然是唯一可以通过手术治愈的肺动脉高压形式。不幸的是,CTEPH 在 CTPA 中经常被误诊,这可能是由于技术因素、患者相关因素、放射科医生相关因素以及许多疾病模拟物引起的,包括急性肺栓塞、原位血栓形成、血管炎、肺动脉肉瘤和纤维性纵隔炎。尽管与 CTPA 相比,V/Q 扫描被认为对 CTEPH 更敏感,但这可能是由于缺乏对 CTEPH 发现的认识,而不是由于模态限制。肺血栓内膜切除术(PTE)的术前评估包括评估技术可操作性和手术风险分层。虽然 PTE 是 CTEPH 的明确治疗方法,但其他微创或非侵入性治疗方法也可导致临床改善,包括提高生存率。PTE 术后影像学可识别的并发症包括感染、再灌注水肿或损伤、肺出血、心包积液或血心包和再血栓形成。RSNA,2022 年